IGF1 and pachyonychia congenita: As demonstrated in an experimental rat model for PC bone metastases, high IGF-1 levels within the bone environment may counteract effects of castration in PC metastases and, furthermore, IGF receptor inhibition could possibly be used to strengthen the ADT response in bone metastases [37].